Comparator Drug

DRUG3 trials

Sponsors

Eisai Inc., Daiichi Sankyo, ChainGen Biopharma Ltd

Conditions

Alzheimer s DiseaseBaseline Epidemiologic AssessmentSolid Tumors

Phase 1

SAD Study of CGB3002 in Healthy Participants

RecruitingNCT07660341

ChainGen Biopharma LtdAlzheimer s Disease

Start: 2026-06-30End: 2027-04-30Target: 46Updated: 2026-07-08

Phase 2

Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials

CompletedNCT03477175

Eisai Inc.Solid Tumors

Start: 2018-08-16End: 2023-12-21Updated: 2025-01-07

Unknown Phase

Baseline Epidemiologic Assessment of Abuse-Deterrence of MorphaBond Extended Release (BEAD-MB)

CompletedNCT04033094

Daiichi SankyoBaseline Epidemiologic Assessment

Start: 2017-10-16End: 2020-12-31Updated: 2021-03-15